Background: Mitral annular disjunction (MAD) is a structural abnormality where there is a separation between the mitral valve annulus and the left atrial wall which is not well understood.
Methods: We conducted a systematic review to evaluate the prevalence of MAD, factors associated with MAD and clinical outcomes among patients with MAD.
Results: A total of 19 studies were included in this review, and the number of noncase report studies had between 23 and 1439 patients. The pooled rate of MAD in studies of myxomatous mitral valve patients was 66/130 (50.8%, 3 studies), and among patients with mitral valve prolapse was 95/291 (32.6%, 3 studies). One study suggests that 78% of patients with MAD had mitral valve prolapse, and another suggested it was strongly associated with myxomatous mitral valve disease (HR 5.04 95% CI 1.66-15.31). In terms of clinical significance, it has been reported that MAD with disjunction > 8.5 mm was associated with nonsustained ventricular tachycardia (OR 10 95% CI 1.28-78.1). There is also evidence that gadolinium enhancement in papillary muscle (OR 4.09 95% CI 1.28-13.05) and longitudinal MAD distance in posterolateral wall (OR 1.16 95% CI 1.02-1.33) was predictive of ventricular arrhythmia and late gadolinium enhancement in anterolateral papillary muscle was strongly associated with serious arrhythmic event (OR 7.35 95% CI 1.15-47.02).
Conclusions: Mitral annular disjunction appears to be common in myxomatous mitral valve disease and mitral valve prolapse which can be detected on cardiac imaging and may be important because of its association with ventricular arrhythmias and sudden cardiac death.
Keywords: cardiac magnetic resonance imaging; echocardiography; mitral annular disjunction.
© 2019 Wiley Periodicals, Inc.
The Mitral Annulus Disjunction Arrhythmic Syndrome.J Am Coll Cardiol. 2018 Oct 2;72(14):1600-1609. doi: 10.1016/j.jacc.2018.07.070. J Am Coll Cardiol. 2018. PMID: 30261961 Clinical Trial.
Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography.Cardiovasc Ultrasound. 2010 Dec 9;8:53. doi: 10.1186/1476-7120-8-53. Cardiovasc Ultrasound. 2010. PMID: 21143934 Free PMC article.
Usefulness of 3-Tesla Cardiac Magnetic Resonance to Detect Mitral Annular Disjunction in Patients With Mitral Valve Prolapse.Am J Cardiol. 2019 Dec 1;124(11):1725-1730. doi: 10.1016/j.amjcard.2019.08.047. Epub 2019 Sep 10. Am J Cardiol. 2019. PMID: 31606191
Arrhythmic Mitral Valve Prolapse: JACC Review Topic of the Week.J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2904-2914. doi: 10.1016/j.jacc.2018.09.048. J Am Coll Cardiol. 2018. PMID: 30522653 Review.
The pathology of mitral valve prolapse.Herz. 1988 Aug;13(4):215-26. Herz. 1988. PMID: 3049284 Review.
- Carmo P, Andrade MJ, Aguiar C, Rodrigues R, Gouveia R, Silva JA. Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography. Cardiovasc Ultrasound. 2010;8:53.
- Eriksson MJ, Bitkover CY, Omran AS, et al. Mitral annular disjunction in advanced myxomatous mitral valve disease: echocardiographic detection and surgical correction. J Am Soc Echocardiogr. 2005;18:1014-1022.
- Hutchins GM, Moore GW, Skoog DK. The association of floppy mitral valve with disjunction of the mitral annulus fibrosis. N Engl J Med. 1986;314:535-540.
- Dejgaard LA, Skjolsvik ET, Lie OH, et al. The mitral annulus disjunction arrhythmic syndrome. J Am Coll Cardiol. 2018;72:1600-1609.
- Perazzolo Marra M, Basso C, De Lazzari M, et al. Morphofunctional abnormalities of mitral annulus and arrhythmic mitral valve prolapse. Circ Cardiovasc Imaging. 2016;9:e005030.